A Study to Evaluate Navelbine in Combination With Trastuzumab Plus Pertuzumab in Patients With HER2 Positive Early Stage or Locally Advanced Breast Cancer in Neoadjuvant Treatment
Latest Information Update: 03 Mar 2023
At a glance
- Drugs Vinorelbine (Primary) ; Docetaxel; Pertuzumab; Trastuzumab
- Indications Advanced breast cancer; Early breast cancer; HER2 positive breast cancer
- Focus Therapeutic Use
- 19 Dec 2020 New trial record